GPT and gastroenteritis: Seven patients (13%) experienced transient dose interruptions for AEs (1 each: nausea, ALT increase, gastroenteritis, GGT increased, thoracic pain, post procedural cellulitis, LDH increase, abdominal pain and atrial fibrillation).